Gateway Biotechnology
Durham, US · North Carolina corporation
Founders & leadership
JB
Jianxin BaoNamed on SEC filing
Board
PP
Philip PerezBoard director
RC
Richard CholeBoard director
Reported raises · per SEC filings
Form D private placements$633K disclosed across 1 round · 2025
▶$633KraisedJun 2025 · 4 investors · BiotechnologyRule 506(b)
▶$633KraisedJun 2025 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jianxin BaoExecutive Officer
- Philip PerezDirector
- Richard CholeDirector
- Offering amount
- $2.4M
- Amount sold
- $633K
- Minimum investment
- $10K
- Placement agents
- Folla Capital, LLC
- First sale
- May 2025
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Gateway Biotechnology raised?
- Gateway Biotechnology has disclosed $633K raised across 1 round.
- Where is Gateway Biotechnology headquartered?
- Gateway Biotechnology is headquartered in Durham, US.